187 related articles for article (PubMed ID: 22887470)
21. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
[TBL] [Abstract][Full Text] [Related]
22. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
23. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.
Tian X; Yang F; Yang C; Peng Y; Chen D; Zhu J; He F; Li L; Chen X
Int J Nanomedicine; 2014; 9():4043-53. PubMed ID: 25187708
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis.
Chaudhury B; Zhou M; Goldgof DB; Hall LO; Gatenby RA; Gillies RJ; Patel BK; Weinfurtner RJ; Drukteinis JS
J Magn Reson Imaging; 2015 Nov; 42(5):1421-30. PubMed ID: 25884277
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T).
Granato L; Longo D; Boutry S; Vander Elst L; Henoumont C; Aime S; Muller RN; Laurent S
Chem Biodivers; 2019 Nov; 16(11):e1900322. PubMed ID: 31544357
[TBL] [Abstract][Full Text] [Related]
27. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
28. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.
Donahue KM; Burstein D; Manning WJ; Gray ML
Magn Reson Med; 1994 Jul; 32(1):66-76. PubMed ID: 8084239
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.
Han Z; Cheng H; Parvani JG; Zhou Z; Lu ZR
Magn Reson Med; 2018 Jun; 79(6):3135-3143. PubMed ID: 29082597
[TBL] [Abstract][Full Text] [Related]
30. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration.
Ghaghada K; Hawley C; Kawaji K; Annapragada A; Mukundan S
Acad Radiol; 2008 Oct; 15(10):1259-63. PubMed ID: 18790397
[TBL] [Abstract][Full Text] [Related]
31. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
32. Sensitive MRI detection of internalized T1 contrast agents using magnetization transfer contrast.
Delli Castelli D; Ferrauto G; Di Gregorio E; Terreno E; Aime S
NMR Biomed; 2015 Dec; 28(12):1663-70. PubMed ID: 26474109
[TBL] [Abstract][Full Text] [Related]
33. Development of a diagnostic polymersome system for potential imaging delivery.
Huang WC; Chen YC; Hsu YH; Hsieh WY; Chiu HC
Colloids Surf B Biointerfaces; 2015 Apr; 128():67-76. PubMed ID: 25731095
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
[TBL] [Abstract][Full Text] [Related]
35. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
[TBL] [Abstract][Full Text] [Related]
36. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
37. Responsive MRI agents for sensing metabolism in vivo.
De Leon-Rodriguez LM; Lubag AJ; Malloy CR; Martinez GV; Gillies RJ; Sherry AD
Acc Chem Res; 2009 Jul; 42(7):948-57. PubMed ID: 19265438
[TBL] [Abstract][Full Text] [Related]
38. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
[TBL] [Abstract][Full Text] [Related]
39. Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study.
Matsuda M; Kido T; Tsuda T; Okada K; Shiraishi Y; Suekuni H; Kamei Y; Kitazawa R; Mochizuki T
Clin Radiol; 2020 May; 75(5):398.e1-398.e8. PubMed ID: 32019671
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
